PHARMAVEST ApS: Financial statements 2013
CVR: 26385180
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
PHARMAVEST ApS (CVR 26385180) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 1,435,221 and a net result of DKK 415,767 compared with DKK 736,953 the year before. That is a decrease of 12.6% compared with the year before. Equity in the 2013 report amounted to DKK 2,803,180. The solvency ratio was 82.4%.
- Gross Profit
- DKK 1,435,221
- Profit/Loss
- DKK 415,767
- Equity
- DKK 2,803,180
- Total Assets
- DKK 3,402,278
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 1.4 mio. | 416 t. | 2.8 mio. | - |
| 2012 | - | 1.6 mio. | 737 t. | 2.9 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
PHARMAVEST ApS has published its annual report for 2012. Gross profit came to DKK 1,641,777, and the net result was DKK 736,953.
As of January 1, 2013, AP STATSAUTORISEREDE REVISORER P/S has been appointed auditor of PHARMAVEST ApS.
About PHARMAVEST ApS
PHARMAVEST ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named PHARMAVEST A/S and PBH 28.037 ApS. The management consists of Frank Orluff Lydig Kristensen. The company is owned by FRANK LYDIG HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 812,233 and a net result of DKK -167,231 compared with DKK 271,222 the year before. Equity in the 2025 report amounted to DKK 4,349,573.